| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.96B | 46.57B | 47.94B | 51.20B | 44.16B | 38.13B |
| Gross Profit | 13.09B | 12.88B | 12.65B | 13.07B | 11.67B | 9.45B |
| EBITDA | 6.76B | 7.49B | 7.05B | 6.74B | 5.86B | 3.38B |
| Net Income | 2.81B | 2.84B | 2.67B | 3.00B | 2.52B | 456.00M |
Balance Sheet | ||||||
| Total Assets | 60.31B | 61.72B | 57.30B | 55.38B | 51.58B | 48.63B |
| Cash, Cash Equivalents and Short-Term Investments | 5.99B | 8.46B | 8.60B | 6.13B | 6.94B | 8.44B |
| Total Debt | 18.78B | 17.84B | 15.55B | 14.37B | 14.23B | 15.62B |
| Total Liabilities | 36.18B | 36.07B | 33.54B | 32.22B | 30.46B | 30.42B |
| Stockholders Equity | 23.57B | 25.14B | 23.27B | 22.71B | 20.71B | 17.89B |
Cash Flow | ||||||
| Free Cash Flow | 3.28B | 3.49B | 4.06B | 3.82B | 3.00B | 3.48B |
| Operating Cash Flow | 5.50B | 5.57B | 6.04B | 5.71B | 4.44B | 4.71B |
| Investing Cash Flow | -6.49B | -5.27B | -3.23B | -4.84B | -2.18B | 194.00M |
| Financing Cash Flow | -1.10B | -402.00M | -209.00M | -1.85B | -3.81B | -1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $93.52B | 32.46 | 37.07% | 0.88% | 8.58% | 20.37% | |
70 Outperform | $80.27B | 24.39 | 11.86% | 1.23% | -10.19% | 100.65% | |
68 Neutral | $47.16B | 22.47 | 9.44% | 1.61% | -7.93% | -35.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $47.80B | 15.62 | 11.48% | 2.61% | 1.66% | -0.30% | |
61 Neutral | $16.73B | 20.13 | 92.25% | 1.03% | 3.77% | 12.46% | |
59 Neutral | $11.77B | 20.25 | 13.56% | ― | -6.44% | -48.84% |